Glucose transporter 1, distribution in the brain and in neural disorders: Its relationship with transport of neuroactive drugs through the blood-brain barrier

Biochemical Genetics

Volumn 43, Issue 3-4, 2005, Pages 175-187

  Xiuli, Guo ^a,b   Meiyu, Geng ^a   Guanhua, Du ^c  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b SHANDONG UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Blood brain barrier; Distribution in brain; Expression in brain disease; Glucose transporter; Neuroactive drug; Saccharide

Indexed keywords

DELTORPHIN; DERMORPHIN DERIVATIVE; GLUCOSE DERIVATIVE; GLUCOSE TRANSPORTER 1; GLYCOPEPTIDE; HEPARIN; LEUCINE ENKEPHALIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; MORPHINE 6 GLUCURONIDE; OPIATE; PEPTIDE; TYROSYL DEXTRO ALANYLPHENYLALANYLASPARTYLVALYLVALYLGLYCYLAMIDE; TYROSYL DEXTRO ALANYLPHENYLALANYLGLYCYLTYROSYLPROLYLSERYLAMIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM; CHEMICAL MODIFICATION; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TRANSPORT; EPILEPSY; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; MOLECULAR WEIGHT; PROTEIN EXPRESSION; REVIEW;

ALZHEIMER DISEASE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; BRAIN DISEASES; BRAIN INJURIES; BRAIN ISCHEMIA; EPILEPSY; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLYCOPEPTIDES; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; PEPTIDES;

EID: 17444384164     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-005-1510-5     Document Type: Review

References (57)

1. Au, K. K., Liong, E., Li, J. Y., Li, P. S., Liew, C. C., Kwok, T. T., Choy, Y. M., Lee, C. Y., and Fung, K. P. (1997). Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development. J. Cell Biochem. 67:131-135.
2. Bergsneider, M., Hovda, D. A., Shalmon, E., Kelly, D. F., Vespa, P. M., Martin, N. A., Phelps, M. E., McArthur, D. L., Caron, M. J., Kraus, J. F., and Becker, D. P. (1997). Cerebral hyperglycolysis following severe traumatic brain injury in humans: A positron emission tomography study. J. Neurosurg. 86:241-251.
3. Bilsky, E. J., Egleton, R. D., Mitchell, S. A., Palian, M. M., Davis, P., huber, J. D., Jones, H., Yamamura, H. I., Janders, J., Davis, T. P., Porreca, F., Hruby, V. J., and Polt, R. (2000). Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability. J. Med. Chem. 43:2586-2590.
4. Boado, R. J. (1998a). Molecular regulation of the blood-brain barrier GLUT 1 glucose transporter by brain-derived factors. J. Neural. Transm. Suppl. 53:323-331.
5. Boado, R. J. (1998b). Brain-derived peptides increase blood-brain barrier GLUT1 glucose transporter gene expression via mRNA stabilization. Neurosci. Lett. 255:147-150.
6. Bolz, S., Farrell, C. L., Dietz, K., and Wolburg, H. (1996). Subcellular distribution of glucose transporter (GLUT-1) during development of the blood-brain barrier in rats. Cell Tissue Res. 284:355-365.
7. Bourasset, F., Cisternino, S., Temsamani, J., and Scherrmann, J. M. (2003). Evidence for an active transport of morphine-6-β-D-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J. Neurochem. 86:1564-1567.
8. Chavez, J. C., and LaManna, J. C. (2002). Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: Potential role of insulin-like growth factor-1. J. Neurosci. 22:8922-8931.
9. Cheng, C. M., Cohen, M., Wang, J., and Bondy, C. A. (2001). Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J. 15:907-915.
10. 18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: Reduced capillary influx. Ann. Neurol. 43:801-808.
11. Cornford, E. M., Hyman, S., Black, K. L., Cornford, M. E., Vinters, H. V., and Pardridge, W. M. (1995). High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium. J. Neuropathol. Exp. Neurol. 54:842-851.
12. Cornford, E. M., Hyman, S., Cornford, M. E., and Caron, M. J. (1996). Glut1 glucose transporter activity in human brain injury. J. Neurotrauma 13:523-536.
13. Cornford, E. M., Hyman, S., Cornford, M. E., Landaw, E. M., and Delgado-Escueta, A. V. (1998b). Interictal seizure resections show two configurations of endothelial GLUT1 glucose transporter in the human blood-brain barrier. J. Cereb. Blood Flow Metab. 18:26-42.
14. Cornford, E. M., Hyman, S., and Pardridge, W. M. (1993). An electron microscopic immunogold analysis of developmental up-regulation of the blood-brain barrier GLUT1 glucose transporter. J. Cereb. Blood Flow Metab. 13:841-854.
15. Doege, H., Bocianski, A., Scheepers, A., Axer, H., Eckel, J., Joost, H. G., and Schürmann, A. (2001). Characterization of glucose transporter 10 (GLUT10), a novel heart and skeletal muscle-specific sugar transport facilitator. Diabetes 50(Suppl 2):A277-A278.
16. Doege, H., Schürmann, A., Bahrenberg, G., Brauers, A., and Joost, H. G. (2000). GLUT8, a novel member of the sugar transport facilitator family with glucose transport activity. J. Biol. Chem. 275:16275-16280.
17. Egleton, R. D., and Davis, T. P. (1997). Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 18:1431-1439.
18. Egleton, R. D., Mitchell, S. A., Huber, J. D., Janders, J., Stropova, D., Polt, R., Yamamura, H. I., Hruby, V. J., and Davis, T. P. (2000). Improved bioavailability to the brain of glycosylated met-enkephalin analogs. Brain Res. 881:37-46.
19. Farrell, C. L., and Pardridge, W. M. (1991). Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: An electron microscopic immunogold study. Proc. Natl. Acad. Sci. U.S.A. 88:5779-5783.
20. Filira, F., Biondi, L., Cavaggion, F., Scolaro, B., and Rocchi, R. (1990). Synthesis of O-glycosylated tuftsins by utilizing threonine derivatives containing an unprotected monosaccharide moiety. Int. J. Pept. Protein Res. 36:86-96.
21. Halmos, T., Santarromana, M., Antonakis, K., and Scherman, D. (1997). Synthesis of O-methylsulfonyl derivatives of D-glucose as potential alkylating agents for targeted drug delivery to the brain: Evaluation of their interaction with the human erythrocyte Glut1 hexose transporter. Carbohyd. Res. 299:15-21.
22. Hamlin, G. P., Cernak, I., Wixey, J. A., and Vink, R. (2001). Increased expression of neuronal glucose transporter 3 but not glial glucose transporter 1 following severe diffuse traumatic brain injury in rats. J. Neurotrauma 18:1011-1018.
23. Harr, S. D., Simonian, N. A., and Hyman, B. T. (1995). Functional alterations in Alzheimer's disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J. Neuropathol. Exp. Neurol. 54:38-41.
24. Horvat, S., Horvat, J., Varga-Defterdarovic, L., Pavelic, K., Chung, N. N., and Schiller, P. W. (1993). Methionine-enkephalin related glycoconjugates: Synthesis and biological activity. Int. J. Pept. Protein Res. 41:399-404.
25. Janigro, D. (1999). Blood-brain barrier, ion homeostasis, and epilepsy: Possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res. 37:223-232.
26. Joost, H. G., Doege, H., Bocianski, A., and Schürmann, A. (2001). Erratum: Nomenclature of the GLUT family of sugar transport facilitators, GLUT6, GLUT9, GLUT10, and Glut11. Biochem. J. 358:791-792.
27. Joost, H. G., and Thorens, B. (2001). The extended GLUT family of sugar/polyol transport facilitators: Nomenclature, sequence characteristics, and potential function of its novel members. Mol. Membr. Bio. 18:247-256.
28. Kayano, T., Burant, C. F., Fukumoto, H., Gould, G. M., Fan, Y.-S., Eddy, R. L., Byers, M. G., Shows, T. B., Seino, S., and Bell, G. I. (1990). Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6). J. Biol. Chem. 265:13276-13282.
29. Klepper, J., Diefenbach, S., Kohlschutter, A., and Voit, T. (2004). Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot. Essent. Fatty Acids 70:321-327.
30. Kondo, F., Asanuma, M., Miyazaki, I., Kondo, Y., Tanaka, K., Makino, H., and Ogawa, N. (2001). Progressive cortical atrophy after forebrain ischemia in diabetic rats. Neurosci. Res. 39:339-346.
31. Kriss, C. T., Lou, B.-S., Szabo, L. Z., Mitchell, S. A., Hruby, V. J., and Polt, R. (2000). Enkephalin-based drug design: Conformational analysis of O-linked glycopeptides by NMR and molecular modeling. Tetrahedron-Asymmetr. 11:9-25.
32. Leino, R. L., Gerhart, D. Z., Duelli, R., Enerson, B. E., and Drewes, L. R. (2001). Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem. Int. 38:519-527.
33. Leveugle, B., Ding, W., Laurence, F., Dehouck, M. P., Scanameo, A., Cecchelli, R., and Fillit, H. (1998). Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide. J. Neurochem. 70:736-744.
34. Ma, Q., Dudas, B., Hejna, M., Cornelli, U., Lee, J. M., Lorens, S., Mervis, R., Hanin, I., and Fareed, J. (2002). The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. Thromb. Res. 105:447-53.
35. Maher, F. (1995). Immunolocalization of GLUT1 and GLUT3 glucose transporters in primary cultured neurons and glia. J. Neurosci. Res. 42:459-469.
36. Maher, F., Davies-Hill, T. M., Lysko, P. G., Henneberry, R. C., and Simpson, I. A. (1991). Expression of two glucose transporters, GLUT1 and GLUT3. Mol. Cell Neurosci. 2:351-360.
37. Maher, F., Vannucci, S. J., and Simpson, I. A. (1994). Glucose transporter proteins in brain. FASEB J. 8:1003-1011.
38. McVie-Wylie, A. J., Lamson, D. R., and Chen, Y. T. (2001). Molecular cloning of a novel member of the GLUT family of transporters SLC2a10 (GLUT10), localized on chromosome 20q13.1: A candidate gene for NIDDM susceptibility. Genomics 72:113-117.
39. Mitchell, S. A., Pratt, M. R., Hruby, V. J., and Polt, R. (2001). Solid-phase synthesis of O-linked glycopeptide analogues of enkephalin. J. Org. Chem. 66:2327-2342.
40. Mooradian, A. D., Chung, H. C., and Shah, G. N. (1997). GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol. Aging 18:469-474.
41. Mueckler, M. (1994). Facilitative glucose transporters. Eur. J. Biochem. 219:713-725.
42. Nicchia, G. P., Frigeri, A., Liuzzi, G. M., and Svelto, M. (2003). Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes. FASEB J. 17:1508-1510.
43. Olson, A. L., and Pessin, J. E. (1996). Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu. Rev. Nutr. 16:235-256.
44. Pardridge, W. M., and Boado, R. J. (2000). Molecular cloning and gene expression of the blood-brain barrier glucose transporter. In Pardridge, W. M. (ed.), The Blood-Brain Barrier, Raven, New York, pp. 395-440.
45. Phay, J. E., Hussain, H. B., and Moley, J. F. (2000). Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics 66:217-220.
46. Polt, R., Porreca, F., Szabo, L. Z., Bilsky, E. J., Davis, P., Abbruscato, T. J., Davis, T. P., Harvath, R., Yamamura, H. I., and Hruby, V. J. (1994). Glycopeptide enkephalin analogues produce analgesia in mice: Evidence for penetration of the blood-brain barrier. Proc. Natl. Acad. Sci. 91:7114-7118.
47. Richard, D. E., and Thomas, P. D. (1997). Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 18:1431-1439.
48. Rodriguez, R. E., Rodriguez, F. D., Sacristan, M. P., Torres, J. L., Valencia, G., and Garcia Anton, J. M. (1989). New glycosylpeptide with high antinoceptive activity. Neurosci. Lett. 101:89-94.
49. Rogers, S., Macheda, M. L., Docherty, S. E., Carty, M. D., Henderson, M. A., Soeller, W. C., Gibbs, E. M., James, D. E., and Best, J. D. (2002). Identification of a novel glucose transporter-like protein, GLUT-12. Am. J. Physiol. Endocrinol. Metab. 282:E733-E738.
50. Sasaki, T., Minoshima, S., Shiohama, A., Shinitani, A., Shimizu, A., Asakawa, S., Kawasaki, K., and Shimizu, N. (2001). Molecular cloning of a member of the facilitative glucose transporter gene family GLUT11(SLC2A11) and identification of transcription variants. Biochem. Biophys. Res. Commun. 289:1218-1224.
51. Simpson, I. A., Appel, N. M., Hokari, M., Oki, J., Holman, G. D., Maher, F., Koehler-Stec, E. M., Vannucci, S. J., and Smith, Q. R. (1999). Blood-brain barrier glucose transporter: effects of hypoand hyperglycemia revisited. J. Neurochem. 72:238-247.
52. Simpson, I. A., Chundu, K. R., Davies-Hill, T., Honer, W. G., and Davies, P. (1994). Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35:546-551.
53. Simpson, I. A., Vannucci, S. J., Dejoseph, M. R., and Hawkins, R. A. (2001). Glucose transporter asymmetries in the bovine blood-brain barrier. J. Biol. Chem. 276:12725-12729.
54. Tomatis, R., Marastoni, M., Balboni, G., Guerrini, R., Capasso, A., Sorrentino, L., Santagada, V., Caliendo, G., Lazarus, L. H., and Salvadori, S. (1997). Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides. J. Med. Chem. 40:2948-2952.
55. Vannucci, S. J., Reinhart, R., Maher, F., Bondy, C. A., Lee, W. H., Vannucci, R. C., and Simpson, I. A. (1998). Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Dev. Brain Res. 107:255-264.
56. 5] enkephalin related glycoconjugates with amide type of linkage. Int. J. Pept. Protein Res. 39:12-17.
57. Waddell, I. D., Zomerschoe, A. G., Voice, M. W., and Burchell, A. (1992). Cloning and expression of a hepatic microsomal transport protein. Comparison with liver plasma-membrane glucose transport protein GLUT2. Biochem. J. 286:173-177.